Xanthohumol improves cognition in farnesoid X receptor-deficient mice on a high-fat diet

Xanthohumol improves cognition in farnesoid X receptor-deficient mice on a high-fat diet

Opis bibliograficzny
Główni autorzy:	Payel Kundu, Ines L. Paraiso, Jaewoo Choi, Cristobal L. Miranda, Chrissa Kioussi, Claudia S. Maier, Gerd Bobe, Jan F. Stevens, Jacob Raber
Format:	Artykuł
Język:	English
Wydane:	The Company of Biologists 2022-11-01
Seria:	Disease Models & Mechanisms
Hasła przedmiotowe:	western diet hippocampus water maze ceramides diacylglycerols farnesoid x receptor
Dostęp online:	http://dmm.biologists.org/content/15/11/dmm049820

Podobne zapisy

Theabrownin alleviates nonalcoholic fatty liver disease by inhibiting the intestinal farnesoid X receptor–ceramide axis
od: Jieyi Wang, i wsp.
Wydane: (2024-07-01)

ApoE isoform-dependent effects of xanthohumol on high fat diet-induced cognitive impairments and hippocampal metabolic pathways
od: Payel Kundu, i wsp.
Wydane: (2022-10-01)

Changes in Plasma Bioactive Lipids and Inflammatory Markers during a Half-Marathon in Trained Athletes
od: Melania Gaggini, i wsp.
Wydane: (2021-05-01)

A high‐fat diet supplemented with medium‐chain triglycerides ameliorates hepatic steatosis by reducing ceramide and diacylglycerol accumulation in mice
od: Stephanie Mourad, i wsp.
Wydane: (2024-03-01)

Human Brain Lipidomics: Investigation of Formalin Fixed Brains
od: Aaron W. Beger, i wsp.
Wydane: (2022-06-01)

Effects of Fish Oil and Grape Seed Extract Combination on Hepatic Endogenous Antioxidants and Bioactive Lipids in Diet-Induced Early Stages of Insulin Resistance in Rats
od: Núria Taltavull, i wsp.
Wydane: (2020-06-01)

Two Different Phospholipases C, Isc1 and Pgc1, Cooperate To Regulate Mitochondrial Function
od: Maria Balazova, i wsp.
Wydane: (2022-12-01)

Onset of Senescence and Steatosis in Hepatocytes as a Consequence of a Shift in the Diacylglycerol/Ceramide Balance at the Plasma Membrane
od: Gergana Deevska, i wsp.
Wydane: (2021-05-01)

Gypenosides ameliorate high-fat diet-induced non-alcoholic steatohepatitis via farnesoid X receptor activation
od: Hongshan Li, i wsp.
Wydane: (2022-08-01)

Stimulation of the farnesoid X receptor promotes M2 macrophage polarization
od: Thiranut Jaroonwitchawan, i wsp.
Wydane: (2023-01-01)

Induction of farnesoid X receptor signaling in germ-free mice colonized with a human microbiota
od: Annika Wahlström, i wsp.
Wydane: (2017-02-01)

Farnesoid X Receptor, Bile Acid Metabolism, and Gut Microbiota
od: Hideki Mori, i wsp.
Wydane: (2022-07-01)

Effect of a Farnesoid X-receptor Agonist on Postprandial Lipemia in Rats Fed a Supraphysiological Fat Dozes
od: Yu. N. Alekhin, i wsp.
Wydane: (2023-05-01)

Imaging the early stages of phospholipase C/sphingomyelinase activity on vesicles containing coexisting ordered-disordered and gel-fluid domains[S]
od: Maitane Ibarguren, i wsp.
Wydane: (2011-04-01)

Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromes
od: Apollinariya V. Bogolyubova, i wsp.
Wydane: (2017-12-01)

Natural Products Targeting Liver X Receptors or Farnesoid X Receptor
od: Jianglian She, i wsp.
Wydane: (2022-01-01)

Farnesoid X Receptor Expression in Microscopic Colitis: A Potential Role in Disease Etiopathogenesis
od: Joana Torres, i wsp.
Wydane: (2017-10-01)

Role of farnesoid X receptor and bile acids in alcoholic liver disease
od: Sharon Manley, i wsp.
Wydane: (2015-03-01)

Experimental Activation of Endocannabinoid System Reveals Antilipotoxic Effects on Cardiac Myocytes
od: Ewa Harasim-Symbor, i wsp.
Wydane: (2020-04-01)

Phospholipases and Membrane Curvature: What Is Happening at the Surface?
od: María Laura Fanani, i wsp.
Wydane: (2023-02-01)

Punicalagin alleviates hypercholesterolemia in mice through modulating farnesoid X receptor signaling and modulating gut microbiota
od: Huanhuan Liu, i wsp.
Wydane: (2025-01-01)

A combined nanotherapeutic approach targeting farnesoid X receptor, ferroptosis, and fibrosis for nonalcoholic steatohepatitis treatment
od: Jiangtao Fu, i wsp.
Wydane: (2024-05-01)

Restraint stress promotes nonalcoholic steatohepatitis by regulating the farnesoid X receptor/NLRP3 signaling pathway
od: Yang Fan, i wsp.
Wydane: (2023-11-01)

PRIMIS: design of a pivotal, randomized, phase 3 study evaluating the safety and efficacy of the nonsteroidal farnesoid X receptor agonist cilofexor in noncirrhotic patients with primary sclerosing cholangitis
od: Michael Trauner, i wsp.
Wydane: (2023-03-01)

Saffron offers hepatoprotection via up-regulation of hepatic farnesoid-X-activated receptors in a rat model of acetaminophen-induced hepatotoxicity
od: Vahid Jamshidi, i wsp.
Wydane: (2021-11-01)

Peroxisome proliferator-activated receptors, farnesoid X receptor, and dual modulating drugs in hypertension
od: John D. Imig
Wydane: (2023-06-01)

Bile Acids Elevated in Chronic Periaortitis Could Activate Farnesoid-X-Receptor to Suppress IL-6 Production by Macrophages
od: Shan Cao, i wsp.
Wydane: (2021-04-01)

Loss of Farnesoid X receptor (FXR) accelerates dysregulated glucose and renal injury in db/db mice
od: Yuxiang Qiu, i wsp.
Wydane: (2023-09-01)

Proteomics and lipidomic analysis reveal dysregulated pathways associated with loss of sacsin
od: Daniele Galatolo, i wsp.
Wydane: (2024-06-01)

Structural basis of the farnesoid X receptor/retinoid X receptor heterodimer on inverted repeat DNA
od: Longying Jiang, i wsp.
Wydane: (2023-01-01)

Alpha-linolenic acid inhibits hepatocellular carcinoma cell growth through Farnesoid X receptor/β-catenin signaling pathway
od: Shu Feng, i wsp.
Wydane: (2022-08-01)

Upregulation of microRNA-23b-3p induced by farnesoid X receptor regulates the proliferation and apoptosis of osteosarcoma cells
od: Bin Wu, i wsp.
Wydane: (2019-11-01)

Farnesoid X receptor regulates forkhead Box O3a activation in ethanol-induced autophagy and hepatotoxicity
od: Sharon Manley, i wsp.
Wydane: (2014-01-01)

Role of farnesoid X receptor in establishment of ontogeny of phase-I drug metabolizing enzyme genes in mouse liver
od: Lai Peng, i wsp.
Wydane: (2016-09-01)

Computational study of novel natural agonists targeting farnesoid X receptor
od: Xindan Hu, i wsp.
Wydane: (2024-07-01)

Arbutin Alleviates the Liver Injury of α-Naphthylisothiocyanate-induced Cholestasis Through Farnesoid X Receptor Activation
od: Peijie Wu, i wsp.
Wydane: (2021-12-01)

Mangrove Tirucallane- and Apotirucallane-Type Triterpenoids: Structure Diversity of the C-17 Side-Chain and Natural Agonists of Human Farnesoid/Pregnane–X–Receptor
od: Zhong-Ping Jiang, i wsp.
Wydane: (2018-12-01)

The Pathophysiology of Farnesoid X Receptor (FXR) in the GI Tract: Inflammation, Barrier Function and Innate Immunity
od: Kemp M. Anderson, i wsp.
Wydane: (2021-11-01)

TO901317 regulating apolipoprotein M expression mediates via the farnesoid X receptor pathway in Caco-2 cells
od: Berggren-Söderlund Maria, i wsp.
Wydane: (2011-11-01)

Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer
od: Mengjiao Zhou, i wsp.
Wydane: (2022-10-01)